Skip to content
You are now leaving to visit

Ionis Reports Third Quarter 2018 Financial Results

Year-to-date revenues increased more than 15% compared to 2017, driven by increased SPINRAZA revenue TEGSEDI launch underway in multiple markets Conference call and webcast today, November 6, 2018, at 11:30 a.m. Eastern Time CARLSBAD, Calif. , Nov. 6, 2018 /PRNewswire/ —  Ionis Pharmaceuticals,